This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Barely Surviving To Thriving - A Remarkable 27-year Journey With HIV

OTTAWA, Nov. 26, 2012 /CNW/ - Tiko Kerr doesn't look sick. He's a healthy and active man who rows four times a week. He defies anyone's image of a man who has lived with HIV for almost 30 years.

Tiko was diagnosed with HIV in 1985 while living in Australia; he took it as a death sentence. If the virus didn't kill him, the medication available at that time might. Little was known about HIV when Tiko was diagnosed, medications where only just being researched and the stigma and fear associated with HIV/AIDS where overwhelming.

"In those days there were not a lot of medication options, people were dying," said Tiko.

Returning to Canada and settling in Vancouver to focus on his artwork, Tiko struggled to keep his disease in check. Over the next 20 years he would take every new medicine developed. As the virus gained strength, Tiko became resistant to one medication after another, barely keeping Tiko alive.

"By 2005 I was taking every drug available," said Tiko. "I was in an advanced stage and I soon became completely drug resistant."

Tiko learned of a new treatment option but the medicine wasn't yet available in Canada. Tiko, his doctor and a group of individuals with HIV banded together and became advocates to gain access to the new treatment. But time was off the essence. Tiko's viral load, a measurement of the amount of virus in the body, was 700 thousand. Others were dying with a viral load of 500 thousand.

"I didn't have much time," said Tiko. "One man in our group had passed away and I knew I was dying.  I needed to take more action."

Tiko gathered significant public support and finally, in 2006, was granted access through a small clinical trial to the latest treatment. The changes were immediate and they were staggering. Within 5 days of treatment, Tiko's viral load was reduced by 90%. Within a month, the HIV virus was no longer detectable in his body.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free
AAPL $93.74 0.00%
FB $117.58 0.00%
GOOG $693.01 0.00%
TSLA $240.76 0.00%
YHOO $36.60 0.00%


Chart of I:DJI
DOW 17,773.64 -57.12 -0.32%
S&P 500 2,065.30 -10.51 -0.51%
NASDAQ 4,775.3580 -29.9330 -0.62%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs